Tapewire

NYSE · USD

TDOC

Teladoc Health, Inc.

Export transactions ↓
Tapewire entity
1547
SEC CIK
0001477449
Parsed reports
839

Last 12 months

Inside the activity.

1 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202506
Jan 202601
Feb 202600
Mar 202608
Apr 202601
May 202600
Jun 202609
Jul 202603
Aug 202600
Sep 202608
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 16, 2020 Filed Apr 17, 2020 20:03 UTC
Cappucci Gabriel R.Senior VP, Controller and CAO
Exercise / conversionCommon Stock 2,355 $12.21 $28,754.55
Disclosure

SEC source: 0001179110-20-004928 · edgar.xml · nonDerivative · entry 2

Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 20:03 UTC
Cappucci Gabriel R.Senior VP, Controller and CAO
Exercise / conversionCommon Stock 2,734 $9.60 $26,246.40
Disclosure

SEC source: 0001179110-20-004928 · edgar.xml · nonDerivative · entry 1

Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC Exercise / conversionStock Option (right to buy) · Derivative 9,700 $0.00 Strike: $16.64 $0.00
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · derivative · entry 7

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,700 shares

Expires 2026-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in full on May 24, 2017.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC Exercise / conversionStock Option (right to buy) · Derivative 11,927 $0.00 Strike: $10.84 $0.00
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · derivative · entry 6

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 322

Underlying: Common Stock · 11,927 shares

Expires 2026-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in full on May 26, 2017.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC Exercise / conversionStock Option (right to buy) · Derivative 18,373 $0.00 Strike: $17.19 $0.00
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · derivative · entry 5

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,373 shares

Expires 2025-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in three equal annual installments beginning July 1, 2016.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC SaleCommon Stock 40,000 $169.64 $6,785,600.00
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · nonDerivative · entry 4

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,513

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29,2020.

F2 · price: Represents the weighted average price of transactions ranging from $168.05 to $171.31. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC Exercise / conversionCommon Stock 9,700 $16.64 $161,408.00
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · nonDerivative · entry 3

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC Exercise / conversionCommon Stock 11,927 $10.84 $129,288.68
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · nonDerivative · entry 2

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:37 UTC Exercise / conversionCommon Stock 18,373 $17.19 $315,831.87
Disclosure

SEC source: 0001179110-20-004983 · edgar.xml · nonDerivative · entry 1

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:36 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 93,597 $0.00 Strike: $17.99 $0.00
Disclosure

SEC source: 0001179110-20-004982 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,403

Underlying: Common Stock · 93,597 shares

Expires 2026-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 4, 2017. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:36 UTC
Verstraete StephanyChief Marketing Officer
SaleCommon Stock 93,597 $169.63 $15,876,859.11
Disclosure

SEC source: 0001179110-20-004982 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,240

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 2, 2020.

F2 · price: Represents the weighted average price of transactions ranging from $167.69 to $171.19. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 16:36 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 93,597 $17.99 $1,683,810.03
Disclosure

SEC source: 0001179110-20-004982 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,661 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-004985 · edgar.xml · derivative · entry 5

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,089

Underlying: Common Stock · 5,661 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,395 $0.00 Strike: $35.45 $0.00
Disclosure

SEC source: 0001179110-20-004985 · edgar.xml · derivative · entry 4

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,833

Underlying: Common Stock · 1,395 shares

Expires 2027-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 2,670 $165.93 $443,033.10
Disclosure

SEC source: 0001179110-20-004985 · edgar.xml · nonDerivative · entry 3

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,766

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 5,661 $38.55 $218,231.55
Disclosure

SEC source: 0001179110-20-004985 · edgar.xml · nonDerivative · entry 2

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,395 $35.45 $49,452.75
Disclosure

SEC source: 0001179110-20-004985 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,775

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Bucaria MichelleChief Human Resources Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,256 $0.00 Strike: $37.75 $0.00
Disclosure

SEC source: 0001179110-20-004984 · edgar.xml · derivative · entry 3

Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,262

Underlying: Common Stock · 1,256 shares

Expires 2028-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Bucaria MichelleChief Human Resources Officer
SaleCommon Stock 5,295 $165.00 $873,675.00
Disclosure

SEC source: 0001179110-20-004984 · edgar.xml · nonDerivative · entry 2

Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 7, 2020.

Read SEC document
April 16, 2020 Filed Apr 20, 2020 20:38 UTC
Bucaria MichelleChief Human Resources Officer
Exercise / conversionCommon Stock 1,256 $37.75 $47,414.00
Disclosure

SEC source: 0001179110-20-004984 · edgar.xml · nonDerivative · entry 1

Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 20:05 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 3,565 $128.00 $456,320.00
Disclosure

SEC source: 0001179110-20-003396 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,380

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:10 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionRestricted Stock Units · Derivative 1,974 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003227 · edgar.xml · derivative · entry 6

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,748

Underlying: Common Stock · 1,974 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:10 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionPerformance Stock Units · Derivative 2,567 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003227 · edgar.xml · derivative · entry 5

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,132

Underlying: Common Stock · 2,567 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 7,699 performance stock units, vesting in three annual installments beginning on March 4, 2020.

F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 7,699 performance stock units, vesting in three annual installments beginning on March 4, 2020.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:10 UTC
Turitz AndrewSVP - Business Development
Tax withholdingCommon Stock 568 $132.73 $75,390.64
Disclosure

SEC source: 0001179110-20-003227 · edgar.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,711

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:10 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 1,974 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003227 · edgar.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:10 UTC
Turitz AndrewSVP - Business Development
Tax withholdingCommon Stock 1,118 $132.73 $148,392.14
Disclosure

SEC source: 0001179110-20-003227 · edgar.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,305

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:10 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 2,567 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003227 · edgar.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:11 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionRestricted Stock Units · Derivative 3,701 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003229 · edgar.xml · derivative · entry 6

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,402

Underlying: Common Stock · 3,701 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:11 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionPerformance Stock Units · Derivative 4,811 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003229 · edgar.xml · derivative · entry 5

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,623

Underlying: Common Stock · 4,811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 14,434 performance stock units, vesting in three annual installments beginning on March 4, 2020.

F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 14,434 performance stock units, vesting in three annual installments beginning on March 4, 2020.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:11 UTC
Verstraete StephanyChief Marketing Officer
Tax withholdingCommon Stock 1,570 $132.73 $208,386.10
Disclosure

SEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 4

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,240

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:11 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 3,701 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:11 UTC
Verstraete StephanyChief Marketing Officer
Tax withholdingCommon Stock 2,314 $132.73 $307,137.22
Disclosure

SEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,109

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 16:11 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 4,811 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:09 UTC
Gorevic Jason NDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 16,778 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003225 · edgar.xml · derivative · entry 6

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,555

Underlying: Common Stock · 16,778 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:09 UTC
Gorevic Jason NDirector · Chief Executive Officer
Exercise / conversionPerformance Stock Units · Derivative 21,812 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003225 · edgar.xml · derivative · entry 5

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,621

Underlying: Common Stock · 21,812 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 65,433 performance stock units, vesting in three annual installments beginning on March 4, 2020.

F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 65,433 performance stock units, vesting in three annual installments beginning on March 4, 2020.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:09 UTC
Gorevic Jason NDirector · Chief Executive Officer
Tax withholdingCommon Stock 8,065 $132.73 $1,070,467.45
Disclosure

SEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 4

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 681,493

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:09 UTC
Gorevic Jason NDirector · Chief Executive Officer
Exercise / conversionCommon Stock 16,778 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 3

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 689,556

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:09 UTC
Gorevic Jason NDirector · Chief Executive Officer
Tax withholdingCommon Stock 10,486 $132.73 $1,391,806.78
Disclosure

SEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 2

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 672,778

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:09 UTC
Gorevic Jason NDirector · Chief Executive Officer
Exercise / conversionCommon Stock 21,812 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 1

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 683,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionRestricted Stock Units · Derivative 3,454 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003228 · edgar.xml · derivative · entry 6

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,909

Underlying: Common Stock · 3,454 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionPerformance Stock Units · Derivative 4,491 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003228 · edgar.xml · derivative · entry 5

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,981

Underlying: Common Stock · 4,491 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 13,472 performance stock units, vesting in three annual installments beginning on March 4, 2020.

F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 13,472 performance stock units, vesting in three annual installments beginning on March 4, 2020.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Tax withholdingCommon Stock 1,548 $132.73 $205,466.04
Disclosure

SEC source: 0001179110-20-003228 · edgar.xml · nonDerivative · entry 4

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,083

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 3,454 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003228 · edgar.xml · nonDerivative · entry 3

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Tax withholdingCommon Stock 2,160 $132.73 $286,696.80
Disclosure

SEC source: 0001179110-20-003228 · edgar.xml · nonDerivative · entry 2

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,177

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 4,491 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003228 · edgar.xml · nonDerivative · entry 1

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,337

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Levy LewisChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,467 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003226 · edgar.xml · derivative · entry 7

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,935

Underlying: Common Stock · 2,467 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 7,402 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 7,402 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Levy LewisChief Medical Officer
Exercise / conversionPerformance Stock Units · Derivative 3,207 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-003226 · edgar.xml · derivative · entry 6

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,416

Underlying: Common Stock · 3,207 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 9,623 performance stock units, vesting in three annual installments beginning on March 4, 2020.

F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 9,623 performance stock units, vesting in three annual installments beginning on March 4, 2020.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 1,982 $126.51 $250,742.82
Disclosure

SEC source: 0001179110-20-003226 · edgar.xml · nonDerivative · entry 5

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,945

F6 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Levy LewisChief Medical Officer
Tax withholdingCommon Stock 711 $132.73 $94,371.03
Disclosure

SEC source: 0001179110-20-003226 · edgar.xml · nonDerivative · entry 4

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,927

F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.

Read SEC document
March 05, 2020 Filed Mar 6, 2020 21:10 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 2,467 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-003226 · edgar.xml · nonDerivative · entry 3

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.